mfresearch ๐Ÿ”’ Show amounts

SBI SMALL CAP FUND - Direct Plan - Growth

code 125497 Small Cap Fund direct plan ยท growth NAVs 2013-11-18 to 2026-11-09

Benchmark: BSE 250 SMALLCAP (no data) declared: AMFI Fund Performance (Fund-Performance-30-Sep-2026--2031 (4).xlsx), as of 2026-09-30 Compare with:

Growth of โ‚น10,000

From 2013-11-18. Scroll or drag to zoom.

Drawdown

Rolling 3-year CAGR

Returns

periodfundfrom โ†’ to
1M1.14% 2026-10-09 โ†’ 2026-11-09
3M-2.44% 2026-08-07 โ†’ 2026-11-09
6M5.08% 2026-05-08 โ†’ 2026-11-09
1Y4.83% 2025-11-07 โ†’ 2026-11-09
3Y11.20% 2023-11-09 โ†’ 2026-11-09
5Y11.90% 2021-11-09 โ†’ 2026-11-09
7Y20.06% 2019-11-08 โ†’ 2026-11-09
10Y17.93% 2016-11-09 โ†’ 2026-11-09
since inception23.69% 2013-11-18 โ†’ 2026-11-09

Absolute under 1 year, CAGR from 1 year.

Calendar years

year201420152016201720182019202020212022202320242025
fund112.77%22.29%2.64%80.44%-18.64%7.40%35.17%49.11%9.29%26.62%25.30%-4.08%

Rolling returns

lengthperiodsaveragemedianworstbest% positive
1 year2,96125.44%19.18% -24.33%127.97%83%
3 years2,46922.16%22.00% -0.77%44.54%100%
5 years1,97521.35%21.35% 7.39%34.49%100%

Risk and risk-adjusted return

3 years
2023-11 โ€“ 2026-10
5 years
2021-11 โ€“ 2026-10
10 years
2016-11 โ€“ 2026-10
CAGR10.26%11.70%17.01%
volatility17.90%15.75%19.60%
max drawdown-22.42%-22.42%-40.26%
downside deviation11.50%9.88%13.05%
Sharpe ratio0.300.420.63
Sortino ratio0.470.670.95
Calmar ratio0.46--

Category: Small Cap Fund

Overall โ˜…โ˜…โ˜…โ˜†โ˜† (3y โ˜…โ˜…โ˜†โ˜†โ˜† ยท 5y โ˜…โ˜…โ˜†โ˜†โ˜† ยท 10y โ˜…โ˜…โ˜…โ˜…โ˜†) ยท as of 2026-10 ยท 155 months of history

percentile rank (1 = best)3 years
of 24 funds
5 years
of 21 funds
10 years
of 12 funds
return79th90th28th
volatility9th5th10th
Sharpe79th80th28th
Sortino79th75th28th
worst fall18th15th10th
risk-adjusted return (MRAR)70th75th28th

View category โ†’

Ratings: Morningstar method. Differences: risk-free rate: RBI 91-day T-bill (Morningstar uses FBIL MIBOR Overnight for rupee funds); peer groups: SEBI-category groups (D13), not Morningstar Categories; no analyst rating suspensions.

Add to comparison โ†’